Table 3. Flow cytometric data in RA... | American Society of Hematology

Table 3.

Flow cytometric data in RA patients after anti–TNF-α treatment

	Before treatment (n = 12)	After treatment (n = 12)	P
Total BM cells
% CD34⁺/CD71⁺cells	0.35 ± 0.19^3-150	1.15 ± 0.57	.0006
Median (range)	0.32 (0.1-0.6)	1.25 (0.1-1.9)
% CD36⁺/glycoA⁺cells	29.06 ± 6.80	24.29 ± 7.26	.101
Median (range)	28.98 (21.4-42.3)	22.8 (15.9-36.0)
% CD36⁻/glycoA⁺cells	56.17 ± 7.09	64.09 ± 9.12	.0220
Median (range)	57.10 (42.0-67.9)	67.45 (47.6-73.3)
CD34⁺/CD71⁺cell fraction
% 7AAD^poscells	33.11 ± 11.82	19.20 ± 10.60	.0011
Median (range)	37.0 (6.9-45.3)	17.30 (6.9-42.6)
CD36⁺/glycoA⁺cell fraction
% 7AAD^poscells	42.89 ± 22.27	19.34 ± 16.08	.0008
Median (range)	40.44 (6.9-75.49)	14.9 (4.6-53.6)
CD36⁻/glycoA⁺cell fraction
% 7AAD^poscells	2.24 ± 1.71	2.84 ± 1.25	.378
Median (range)	1.55 (1.0-6.49)	2.7 (1.0-5.5)

	Before treatment (n = 12)	After treatment (n = 12)	P
Total BM cells
% CD34⁺/CD71⁺cells	0.35 ± 0.19^3-150	1.15 ± 0.57	.0006
Median (range)	0.32 (0.1-0.6)	1.25 (0.1-1.9)
% CD36⁺/glycoA⁺cells	29.06 ± 6.80	24.29 ± 7.26	.101
Median (range)	28.98 (21.4-42.3)	22.8 (15.9-36.0)
% CD36⁻/glycoA⁺cells	56.17 ± 7.09	64.09 ± 9.12	.0220
Median (range)	57.10 (42.0-67.9)	67.45 (47.6-73.3)
CD34⁺/CD71⁺cell fraction
% 7AAD^poscells	33.11 ± 11.82	19.20 ± 10.60	.0011
Median (range)	37.0 (6.9-45.3)	17.30 (6.9-42.6)
CD36⁺/glycoA⁺cell fraction
% 7AAD^poscells	42.89 ± 22.27	19.34 ± 16.08	.0008
Median (range)	40.44 (6.9-75.49)	14.9 (4.6-53.6)
CD36⁻/glycoA⁺cell fraction
% 7AAD^poscells	2.24 ± 1.71	2.84 ± 1.25	.378
Median (range)	1.55 (1.0-6.49)	2.7 (1.0-5.5)

Statistical analysis was performed using the Student ttest for paired samples. P ≤ .05 was considered statistically significant.

All values are expressed as mean ± SD.